General MedicationsORALStandard

CEFPODOXIME PROXETIL

Standard Dose

EQ 200MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview CEFPODOXIME PROXETIL is listed in Drugs@FDA under application 210568 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CEFPODOXIME PROXETIL Form and strength TABLET;ORAL - EQ 200MG BASE Sponsor ALKEM LABS LTD Submission history Latest submission status date: 2022-05-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFPODOXIME PROXETIL is listed in Drugs@FDA under application 210568 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CEFPODOXIME PROXETIL Form and strength TABLET;ORAL - EQ 200MG BASE Sponsor ALKEM LABS LTD Submission history Latest submission status date: 2022-05-18 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.